SomnoMed is passionate about providing clinically proven treatment options for sleep-related breathing disorders such as obstructive sleep apnoea (OSA) and sleep bruxism. Our world class oral devices are designed with patient comfort and treatment efficacy in mind. Over 650,000 patients have now been treated worldwide with SomnoDent® oral devices.
SomnoMed is proud to support the growing need for continuing education in Dental Sleep Medicine as well as to serve as a resource to organisations seeking education for their members on the use of SomnoDent® therapy.
In the UK, SomnoMed is making a unique investment in an initiative to increase NHS awareness about the effectiveness of oral device treatment in the right patient population. The company is also helping to increase the collaboration between dentists and doctors, which will improve the sleep health of patients suffering from obstructive sleep apnoea.
You can visit their global website here: somnomed.com
You can visit their dedicated website for UK patients here: sompt.co.uk